Zobrazeno 1 - 10
of 70
pro vyhledávání: '"E N Semenkova"'
Autor:
L A Strizhakov, S V Moiseev, E A Kogan, S P Pasha, L Iu Churganova, V E Ditterle, P I Novikov, E N Semenkova, N A Mukhin
Publikováno v:
Терапевтический архив, Vol 86, Iss 12-2, Pp 35-42 (2014)
AIM. To study the rate and types of cardiac involvement, the patterns of cardiovascular events (CVE) and to determine the importance of risk factors for atherosclerosis and the role of noninvasive methods in the diagnosis of cardiovascular diseases i
Externí odkaz:
https://doaj.org/article/ce8df60d31ed4f84a1efc4e174ca5014
Autor:
S V Moiseev, P I Novikov, E N Semenkova, L A Strizhakov, S V Guliaev, T N Ianushkevich, N V Nikiforova, A D Meshkov, V V Panasiuk, Iu D Sorokin, M V Taranova, S A Parfenova, L V Dubrovskaia, E S Zhabina, E I Kuznetsova, I A Lopatina, N M Bulanov, N A Mukhin
Publikováno v:
Терапевтический архив, Vol 85, Iss 5, Pp 37-43 (2013)
AIM: To assess the risk of severe adverse events (AEs) within 6 months after treatment with biological agents in patients with rheumatic diseases (RD)/MATERIAL AND METHODS: The 6-month open-label trial included 107 patients with rheumatoid arthritis,
Externí odkaz:
https://doaj.org/article/5036bbf9a7c740e2b20f00cc162ea769
Autor:
N A Mukhin, P I Novikov, Sergey Valentinovich Moiseev, T M Ignatova, L V Kozlovskaya, E N Semenkova, V V Fomin, S V Gulyaev, T N Krasnova, L A Strizhakov, T N Yanushkevich, V V Panasyuk, N V Nikiforova, S V Roshchupkina, Yu D Sorokin, A D Meshkov, L V Dubrovskaya, E S Zhabina, S A Parfenova, E I Kuznetsova, I A Lopatina
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 2, Pp 138-144 (2013)
There has been a substantial expansion in the possibilities of current therapy for rheumatic diseases (RD) primarily due to the use of genetically engineered biological agents (GEBA). Objective: to evaluate the short-term efficacy and safety of GEBA
Externí odkaz:
https://doaj.org/article/bb698b649c36445299825dd135af1d24
Autor:
Leonid Aleksandrovich Strizhakov, S V Moiseyev, E A Kogan, V E Ditterle, E N Semenkova, E I Kuznetsova
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 4, Pp 18-23 (2012)
Objective: to study the incidence rates of angina, myocardial infarction (MI), stroke, and the frequency of endovascular interventions in patients with systemic vasculitides, and the incidence rate of atherosclerosis according to autopsy data. Subjec
Externí odkaz:
https://doaj.org/article/68b688b3edd345b5aedc2103ab85262e
Publikováno v:
Терапевтический архив, Vol 84, Iss 5, Pp 31-35 (2012)
Russian and foreign data on development of atherosclerosis in patients with primary vasculitis are analysed. The discussion covers the role of risk factors, features of pathogenesis of atherosclerosis in primary vasculitis, diagnostic and therapeutic
Externí odkaz:
https://doaj.org/article/4aa337c8d5dc4adf951c4c31b9a9d091
Autor:
Pavel Igorevich Novikov, O G Krivosheev, Evgeniya Nikolaevna Semenkova, P I Novikov, E N Semenkova
Publikováno v:
Терапевтический архив, Vol 83, Iss 11, Pp 70-76 (2011)
Aim. To assess efficacy of rituximab in patients suffering from Wegener's granulematosis (WG) with renal disease. Material and methods. We analysed clinical laboratory data from 9 WG patients with renal disease treated with rituximab in E.M. Tareev c
Externí odkaz:
https://doaj.org/article/73b95f1e934045be8658856ef2fa570d
Publikováno v:
Терапевтический архив, Vol 80, Iss 12, Pp 69-73 (2008)
Externí odkaz:
https://doaj.org/article/95a327f908164948b7cb15e87dd91b77
Autor:
E N Semenkova, O G Krivosheyev, P I Novikov, V I Osipenko, N R Nosova, S A Parfenova, N V Nikiforova, O O Borodin
Publikováno v:
Терапевтический архив, Vol 82, Iss 6, Pp 53-55 (2010)
The paper discusses the problems of the diagnosis and treatment of Wegener's granulomatosis, the most common anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. It describes a clinical case in which the administration of rituximab co
Externí odkaz:
https://doaj.org/article/e0f16028eacc4a9e9dbbb5b4d0f73d85
Publikováno v:
Терапевтический архив, Vol 79, Iss 10, Pp 23-24 (2004)
Externí odkaz:
https://doaj.org/article/eda4aaf109054e838121532c70e25744
Publikováno v:
Klinicheskaia meditsina. 90(5)
The patients with Wegener's granulomatosis and Schoenlein-Genoch's purpura included in this study were examined in the E.A.M. Tareev Clinic during 2006-2008. They showed signs of hypercoagulation and activation of fibrinolysis, viz. enhanced SFMC, D-